NSTM (NovelStem International) Days Sales Outstanding : 197.71 (As of Sep. 2024)

View and export this data going back to 1995. Start your Free Trial

What is NovelStem International Days Sales Outstanding?

NovelStem International's average Accounts Receivable for the three months ended in Sep. 2024 was $0.01 Mil. NovelStem International's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Hence, NovelStem International's Days Sales Outstanding for the three months ended in Sep. 2024 was 197.71.

The historical rank and industry rank for NovelStem International's Days Sales Outstanding or its related term are showing as below:

NSTM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.41 Med: 46.16 Max: 365
Current: 162.22

During the past 13 years, NovelStem International's highest Days Sales Outstanding was 365.00. The lowest was 9.41. And the median was 46.16.

NSTM's Days Sales Outstanding is ranked worse than
81.78% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: 65.49 vs NSTM: 162.22

NovelStem International's Days Sales Outstanding increased from Sep. 2023 (0.00) to Sep. 2024 (197.71).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

NovelStem International Days Sales Outstanding Historical Data

The historical data trend for NovelStem International's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovelStem International Days Sales Outstanding Chart

NovelStem International Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

179.08

44.44

365.00

NovelStem International Quarterly Data
	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	91.25	121.67	197.71

Competitive Comparison of NovelStem International's Days Sales Outstanding

For the Diagnostics & Research subindustry, NovelStem International's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NovelStem International's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NovelStem International's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where NovelStem International's Days Sales Outstanding falls into.

NovelStem International Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

NovelStem International's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.012	+	0)	/	1 )	/	0.012	*	365
=	0.012					/	0.012	*	365
=	365.00

NovelStem International's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (0.005	+	0.008)	/	2 )	/	0.003	*	365 / 4
=	0.0065					/	0.003	*	365 / 4
=	197.71

NovelStem International (OTCPK:NSTM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

NovelStem International Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of NovelStem International's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

NovelStem International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NovelStem International Corp (OTCPK:NSTM) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

2255 Glades Road, Suite 221A, Boca Raton, FL, USA, 33431

Website

https://www.novelstem.com

NovelStem International Corp focuses on the development and commercialization of diagnostic technology that can predict patients' anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy.

Executives

Baker Street Capital Management, Llc	10 percent owner	1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Vadim Perelman	10 percent owner	1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Baker Street Capital L.p.	10 percent owner	1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Stephen Gans	director, 10 percent owner	14850 NW 44TH COURT, OPA LOCKA FL 33054
Shannon River Partners Lp	10 percent owner	850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Shannon River Fund Management Co Llc	10 percent owner	850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Shannon River Partners Ii, Lp	10 percent owner	850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Doonbeg Fund Lp	10 percent owner	850 THIRD AVE, 13TH FLOOR, New York ny 10022
Spencer M. Waxman	director	C/O SHANNON RIVER PARTNERS, 800 THIRD AVENUE 30TH FLOOR, NEW YORK NY 10022
Stanley Morgan	10 percent owner	1585 BROADWAY, NEW YORK NY 10036
Robert D. Epstein	director	2255 GLADES ROAD, BOCA RATON FL 33431
Coghill Capital Management Llc	10 percent owner	233 SOUTH WACKER DRIVE, SUITE 8439, CHICAGO IL 60606
Ccm Master Fund Ltd	10 percent owner	C/O MORGAN STANLEY FUND SERVICES (CAYMAN, LTD CENTURY YARD CRICKET SQ HUTCHINGS DR, PO BOX 2681 GEORGE TOWN E9 00000
Clint D Coghill	10 percent owner
Scott Gomez	officer: Chief Accounting Officer

NovelStem International Headlines

From GuruFocus

NewStem Announces $4 million Seed Investment

By PRNewswire PRNewswire • 07-16-2018

Hollywood Media Corp. Reports Operating Results (10-Q)

By gurufocus • 05-11-2009

Hollywood Media Corp. Reports Operating Results (10-K/A)

By gurufocus 10qk • 04-30-2010

Hollywood Media Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 05-17-2010